COMy 2022 Achievement Awards

Call to apply/nominate candidates for the “MULTIPLE MYELOMA ACHIEVEMENT AWARD”

The organizing committee of the International Congress on Controversies in Multiple Myeloma (COMy) and the Hematology Department of the Saint-Antoine Hospital, with the support of various professional and Scientific Societies are proud to announce that the application process for the “2022 MULTIPLE MYELOMA ACHIEVEMENT AWARD” is open.

Two awards for the sum of 10,000 Euro each will be presented at the opening session of the 2022 COMy Congress. These awards recognize and reward innovative research that contributed significantly to development and progress in field of Multiple Myeloma and Plasma Cell Dyscrasias in general. The awards will be granted to the clinician/ scientist/institution who gained the most impactful research based on recent peer-reviewed publications in respect to papers published between the years 2016-2021.

The Laureates of the awards will be invited to give a lecture during the COMy Congress that will take place in Paris, France May 12-15, 2022.

Criteria for application:
Significant contribution to the field of interest of the award. The clinical or basic research papers submitted for consideration were published between 2016-2021.

Candidates must submit their detailed CV (maximum of 10 A4 pages, single-spaced, 12 font) A maximum of 25 articles can be presented per candidate.

Only original papers will be mainly evaluated (usually excluding reviews, editorials, and summaries of press releases at Congresses, speeches and retractions).

Only articles for which the candidate is the first or last author will be evaluated. Journal impact factor must be submitted along with the references, in order to allow for calculation of the cumulative impact factor of the candidate.

Deadline for application/ nomination of candidate is March 1, 2022

Please send all applications to: comy@cme-congresses.com.

The COMy Congress Organizing Committee is honored to recognize outstanding individuals and institutions that are continuing to drive fundamental clinical and basic research forward, broadening tomorrow’s scientific and clinical horizons, with the objective of improving patient care in the field of Multiple Myeloma.

Sincerely,

On behalf of the COMy Congress Organizing Committee

Professor Mohamad Mohty, Co-Chair COMy Congress
Professor Arnon Nagler, Co-Chair COMy Congress
Professor Thierry Facon, Co-Chair COMy Congress